Feng Weisheng, Du Bin, Feng Baoju
Department of Emergency, Lianyungang Hospital of Traditional Chinese Medicine, Affiliated Lianyungang Hospital of Nanjing University of Chinese Medicine, Lianyungang 222000, Jiangsu, China.
Department of Medical Intensive Care Unit, Peking Union Medical College Hospital, Beijing 100730, China.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jun;32(6):652-657. doi: 10.3760/cma.j.cn121430-20200529-00422.
Coronavirus disease 2019 (COVID-19) is sweeping the world with strong infectivity and high mortality, but by now, we still lack specific treatment. The leading cause of death from COVID-19 is failure to eliminate those viruses effectively. Cellular immunity plays a crucial role in the body's elimination of coronavirus, so it is necessary to study cellular immunity on the basis of plasma therapy. Blood components of convalescents without erythrocytes contains all the components of cellular immunity and humoral immunity in blood. Current studies had shown that all neutrophils, specific antibodies, interferons, platelets, specific effect cells and memory cells, play irreplaceable roles in the immune process of eradicating coronavirus. This article summarizes the infusion safety, therapeutic mechanism of all above components, and their effects on immunologic derangement and excessive inflammatory response, in order to provide an alternative reference for the treatment of COVID-19.
2019冠状病毒病(COVID-19)正以强大的传染性和高死亡率席卷全球,但到目前为止,我们仍缺乏特效治疗方法。COVID-19导致死亡的主要原因是无法有效清除这些病毒。细胞免疫在机体清除冠状病毒的过程中起着至关重要的作用,因此有必要在血浆治疗的基础上研究细胞免疫。康复者去除红细胞后的血液成分包含了血液中细胞免疫和体液免疫的所有成分。目前的研究表明,所有的中性粒细胞、特异性抗体、干扰素、血小板、特异性效应细胞和记忆细胞在根除冠状病毒的免疫过程中都发挥着不可替代的作用。本文总结了上述所有成分的输注安全性、治疗机制及其对免疫紊乱和过度炎症反应的影响,以期为COVID-19的治疗提供可供选择的参考。